Svoboda | Graniru | BBC Russia | Golosameriki | Facebook

Curcumin exerts a protective effect against premature ovarian failure in mice

J Mol Endocrinol. 2018 Apr;60(3):261-271. doi: 10.1530/JME-17-0214. Epub 2018 Feb 7.

Abstract

This study was designed to investigate the protective effect of curcumin against d-galactose (d-gal)-induced premature ovarian failure (POF) in mice. A mouse POF model was induced by subcutaneous injection of d-gal (200 mg/kg/day) daily for 42 days. Mice in the curcumin group received both d-gal treatment and intraperitoneal injection of curcumin (100 mg/kg/day) for 42 days. Ovarian function, oxidative stress and apoptosis were evaluated. The P, E2 and SOD levels were higher, and the FSH, LH and MDA levels were significantly lower in the curcumin group than those in the d-gal group. The proportion of primordial follicles was also significantly higher in the curcumin group than that in the d-gal group. In addition, curcumin treatment after d-gal administration resulted in significantly lower Sod2, Cat, 8-OhdG, 4-HNE, NTY and senescence-associated protein P16 expression levels, higher Amh expression levels and less apoptosis in granulosa cells than was observed in the d-gal group. Moreover, the p-Akt, Nrf2 and HO-1 protein expression levels were significantly higher and the apoptosis-related cleaved caspase-3 and -9 protein expression levels were markedly lower in the curcumin group than in the d-gal group. In conclusion, curcumin effectively inhibited d-gal-induced oxidative stress, apoptosis and ovarian injury via a mechanism involving the Nrf2/HO-1 and PI3K/Akt signaling pathways, suggesting that curcumin is a potential protective agent against POF.

Keywords: curcumin; d-galactose; ovary aging; oxidative stress; premature ovarian failure.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 8-Hydroxy-2'-Deoxyguanosine
  • Aldehydes / metabolism
  • Animals
  • Anti-Mullerian Hormone / genetics
  • Anti-Mullerian Hormone / metabolism
  • Apoptosis / drug effects
  • Curcumin / pharmacology
  • Curcumin / therapeutic use*
  • Cyclin-Dependent Kinase Inhibitor p16 / metabolism
  • Deoxyguanosine / analogs & derivatives
  • Deoxyguanosine / metabolism
  • Disease Models, Animal
  • Female
  • Galactose
  • Gonads / drug effects
  • Gonads / metabolism
  • Hypothalamo-Hypophyseal System / drug effects
  • Hypothalamo-Hypophyseal System / metabolism
  • Mice, Inbred C57BL
  • Ovary / metabolism
  • Ovary / pathology
  • Oxidative Stress
  • Primary Ovarian Insufficiency / drug therapy*
  • Protective Agents / pharmacology
  • Protective Agents / therapeutic use*
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Tyrosine / analogs & derivatives
  • Tyrosine / metabolism

Substances

  • Aldehydes
  • Cyclin-Dependent Kinase Inhibitor p16
  • Protective Agents
  • RNA, Messenger
  • 3-nitrotyrosine
  • Tyrosine
  • Anti-Mullerian Hormone
  • 8-Hydroxy-2'-Deoxyguanosine
  • Deoxyguanosine
  • Curcumin
  • 4-hydroxy-2-nonenal
  • Galactose